HC Sponsor LLC - 29 Dec 2021 Form 4 Insider Report for Hyperfine, Inc. (HYPR)

Reporting relationship: 10%+ Owner
Issuer ticker: HYPR
Reported as of: 29 Dec 2021
Net transaction value: +$1,359,255
SEC form: 4
Accepted by SEC: 20 Dec 2022, 15:58:30 UTC
Prior SEC filing: 27 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Arthur Bruce Cohen, as Authorized Signatory for HC Sponsor LLC

Key filing fact

HC Sponsor LLC filed Form 4 for Hyperfine, Inc. (HYPR) on 20 Dec 2022.

Key facts

This page summarizes HC Sponsor LLC's Form 4 filing for Hyperfine, Inc. (HYPR).
8 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 20 Dec 2022, 15:58.

Change

Previous filing in this sequence was filed on 27 Dec 2021.
Current net transaction value: +$1,359,255.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $700,000
Shares: +100,000
Change %: +10%
Price: $7.00
Shares after: 1,100,000
Date: 29 Dec 2021
Ownership: See Footnotes
Footnotes: F1, F2

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $91,609
Shares: +13,677
Change %: +1.2%
Price: $6.70
Shares after: 1,113,677
Date: 10 Jan 2022
Ownership: See Footnote
Footnotes: F1, F3

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $19,599
Shares: +2,913
Change %: +0.26%
Price: $6.73
Shares after: 1,116,590
Date: 11 Jan 2022
Ownership: See Footnote
Footnotes: F1, F4

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $55,245
Shares: +8,410
Change %: +0.75%
Price: $6.57
Shares after: 1,125,000
Date: 12 Jan 2022
Ownership: See Footnote
Footnotes: F1, F5

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $112,550
Shares: +25,000
Change %: +2.2%
Price: $4.50
Shares after: 1,150,000
Date: 21 Jan 2022
Ownership: See Footnote
Footnotes: F1

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $292,465
Shares: +78,053
Change %: +6.8%
Price: $3.75
Shares after: 1,228,053
Date: 26 Jan 2022
Ownership: See Footnote
Footnotes: F1, F6

HYPR transaction

Class A Common Stock

Purchase

Transaction value: $87,788
Shares: +21,947
Change %: +1.8%
Price: $4.00
Shares after: 1,250,000
Date: 03 Feb 2022
Ownership: See Footnote
Footnotes: F1

HYPR transaction

Class A Common Stock

Other

Transaction value: $0
Shares: -5,534,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Dec 2022
Ownership: Direct
Footnotes: F1, F7, F8

HYPR holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,534,000
Date: 29 Dec 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

HC Sponsor LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

Footnote F2

Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive.

Footnote F5

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive.

Footnote F6

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive.

Footnote F7

Sponsor distributed these shares to its members on a pro rata basis for no consideration.

Footnote F8

A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly.